Our results showed that ZNF322A overexpression activated Shh-pGL4 promoter activity but marginally changed Mut-Shh-pGL4 promoter activity in both H460 KrasQ61H and H1299 KrasWT lung cancer cells (Figure 3K and 3L). Here, ZNF322 is linked to lung carcinoma.